ASCT2 is physically associated with EGFR in a molecular complex.
Cetuximab downregulates ASCT2 via cetuximab-mediated EGFR endocytosis.
Co-targeting ASCT2 by cetuximab sensitizes HNSCC cells to ROS-induced apoptosis.
Cetuximab sensitizes ROS-induced apoptosis independent of EGFR kinase inhibition.